Back to state act
Description
On 19 December 2025, the U.S. Administration announced reaching an agreement with Amgen. Under the agreement, Amgen will be exempt from industry-specific tariffs on pharmaceutical products for the nex...
Sign in to see full description
Intervention Details
Intervention Type
Tax or social insurance relief
MAST Chapter
L: Subsidies (excl. export subsidies)
Implementation date
31 Jul 2026
Revocation date
20 Jan 2029
Implementation level
National
Affected flow
Inward
Announced as temporary
No
Eligible firms
firm-specific
Affected Trading Partners
Table
Affected Sectors
Sign in to access 1 sectors
Affected Products
Sign in to access 2 products
Threads
See all
This intervention is not part of any Thread yet.